Record high scrips for Mounjaro for weight loss raise concern that urgent medical cases will get left out

Monthly prescriptions of obesity and diabetes management drug Mounjaro have surpassed 200,000 for the first time in March, raising concerns that demand for the drug by people seeking to lose weight could limit access for other patients.

2026-04-16

New study finds that type 2 diabetics with lower BMI have higher mortality rate

Underweight patients with type 2 diabetes face a significantly higher risk of death than those who are obese, with mortality up to five times higher in the most severe cases, according to a large-scale Korean study.

2026-01-06

Korea leads East Asia in childhood obesity as experts urge earlier intervention

Childhood obesity has surged to alarming levels in Korea, which now has the highest rate among children and adolescents in East Asia.

2025-11-20

Huons ups its support for young diabetes patients

Huons has taken the initiative in enhancing convenience for diabetes patients, in alignment with the government’s latest health insurance support policies.

2024-03-08

Enavogliflozin Phase 3 trials to begin in China

Daewoong Pharmaceutical won approval to start Phase 3 clinical trials of Enavogliflozin, a diabetes treatment, from regulators in China.

2022-02-22

LG Chem's LC542019 receives FDA clinical trial approval

An LG Chem diabetes treatment candidate received approval to start Phase 1 clinical trials from the U.S. Food and Drug Administration (FDA), the company said Wednesday.

2022-01-19

Diabetes drugs found to contain cancer-causing contaminant

The Ministry of Food and Drug Safety (MFDS) suspended sales of 31 diabetes drugs containing metformin on Tuesday found to contain high levels of a cancer-causing contaminant known as N-nitrosodimethylamine (NDMA).

2020-05-26

korea joongAng daily